Confidence In Factor XIa Inhibition Wavers After Bristol/Janssen And Bayer Data

High Expectations For Next Big Oral Anticoagulant Drug Class

 
• By Mandy Jackson
Red question mark on a background of black question marks
Phase II trials left several unanswered questions for milvexian and asundexian • Source: Shutterstock

More from Clinical Trials

More from R&D